Key Events This Week
9 Feb: Intraday high of Rs.663.95 with a 7.06% surge
10 Feb: Valuation shifts to fair amid mixed market performance
13 Feb: Week closes at Rs.641.70, down 3.55% on the day
9 February: Strong Intraday Rally Reverses Prior Declines
Jubilant Ingrevia Ltd recorded a robust intraday performance on 9 February 2026, surging 7.06% to touch a day’s high of Rs.663.95. The stock closed at Rs.663.65, marking an 8.02% gain from the previous close of Rs.614.35. This rally ended a three-day losing streak and significantly outpaced the Sensex’s 1.04% gain, reflecting strong buying interest amid elevated volatility.
The stock’s close above its 5-day and 20-day moving averages signalled short-term positive momentum, although it remained below longer-term averages, indicating resistance ahead. The intraday volatility of 5.32% underscored active trading, with buyers maintaining control into the close. This performance contrasted with the broader market, where the Sensex was trading below its 50-day moving average despite a three-week consecutive rise.
Despite the strong price action, Jubilant Ingrevia’s Mojo Score stood at 28.0, categorised as a Strong Sell by MarketsMOJO, reflecting ongoing fundamental and trend challenges. The upgrade to Strong Sell on 5 February 2026 highlighted deteriorating quality grades despite the short-term price strength.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
10 February: Valuation Adjusts to Fair Amid Mixed Market Signals
Following the strong price surge, Jubilant Ingrevia’s valuation metrics shifted from attractive to fair on 10 February. The company’s price-to-earnings (P/E) ratio rose to 38.46, signalling a premium relative to historical averages and many peers. The price-to-book value (P/BV) ratio increased to 3.48, indicating investors were paying over three times the book value for shares.
Other multiples such as EV/EBIT (29.47) and EV/EBITDA (20.57) further highlighted elevated enterprise valuations. Despite this, the PEG ratio of 1.16 suggested a balanced valuation relative to earnings growth prospects, positioning Jubilant Ingrevia in a fair valuation bracket compared to specialty chemicals and pharmaceutical peers.
Operational metrics showed moderate efficiency, with a return on capital employed (ROCE) of 10.56% and return on equity (ROE) of 9.47%. Dividend yield remained modest at 0.38%, consistent with a conservative payout policy. The company’s market capitalisation grade was 3, indicating a mid-tier size within its sector.
The Mojo Score deterioration to 28.0 and downgrade to Strong Sell on 5 February reflected concerns over stretched valuation and earnings momentum headwinds, despite recent price appreciation. This valuation adjustment signals a more cautious stance amid mixed financial performance and sector dynamics.
11–13 February: Mixed Price Movements Amid Market Volatility
On 11 February, Jubilant Ingrevia rebounded modestly, closing at Rs.670.10, up 1.53% from the previous day. This marked the week’s highest close, reinforcing short-term strength. However, the Sensex gained only 0.13%, indicating the stock’s relative outperformance.
The following two days saw declines, with the stock closing at Rs.665.35 (-0.71%) on 12 February and Rs.641.70 (-3.55%) on 13 February. These drops coincided with broader market weakness, as the Sensex fell 0.56% and 1.40% respectively. The stock’s weekly volume remained moderate, reflecting cautious investor sentiment amid valuation concerns and sector headwinds.
Holding Jubilant Ingrevia Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Jubilant Ingrevia vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.663.65 | +8.02% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.660.00 | -0.55% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.670.10 | +1.53% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.665.35 | -0.71% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.641.70 | -3.55% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: Jubilant Ingrevia demonstrated strong short-term momentum with an 8.02% surge on 9 February, outperforming the Sensex by nearly 7 percentage points. The stock’s ability to close above short-term moving averages indicated potential for near-term recovery. Its PEG ratio of 1.16 suggests valuation remains aligned with earnings growth prospects relative to peers.
Cautionary Signals: Despite the weekly gain, the stock closed lower on the final two trading days amid broader market weakness, reflecting vulnerability to sector and market headwinds. Elevated valuation multiples, including a P/E of 38.46 and P/BV of 3.48, imply limited margin for earnings disappointments. The Mojo Score downgrade to Strong Sell highlights ongoing fundamental and trend concerns.
Investors should note the mixed financial performance over longer horizons, with a 5.73% year-to-date decline and a 9.68% drop over the past year contrasting with the Sensex’s positive returns. Operational metrics such as ROCE and ROE remain moderate, underscoring the need for sustained earnings momentum to justify current valuations.
Conclusion
Jubilant Ingrevia Ltd’s week was marked by significant volatility, with a strong intraday rally on 9 February followed by a valuation reassessment and subsequent price corrections. The stock outperformed the Sensex’s decline, closing the week 4.45% higher, supported by short-term technical strength and a balanced PEG ratio. However, elevated valuation multiples and a Strong Sell Mojo Grade reflect caution amid mixed operational and market signals.
As the stock approaches its recent highs, investors should monitor earnings momentum and sector developments closely. The week’s events underscore the importance of balancing short-term price action with fundamental valuation and trend assessments in evaluating Jubilant Ingrevia’s outlook.
Unlock special upgrade rates for a limited period. Start Saving Now →
